Literature DB >> 33460316

Late-onset hypogonadism a challenging task for the andrology field.

Giovanni Corona1, Csilla Krausz2.   

Abstract

Entities:  

Year:  2020        PMID： 33460316     DOI： 10.1111/andr.12917

Source DB:  PubMed          Journal:  Andrology        ISSN： 2047-2919            Impact factor:   3.842


× No keyword cloud information.
  3 in total

1.  Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question.

Authors:  Irene Caramella; Alberto Dalla Volta; Marco Bergamini; Deborah Cosentini; Francesca Valcamonico; Alfredo Berruti
Journal:  Endocrine       Date:  2022-08-20       Impact factor: 3.925

Review 2.  Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age.

Authors:  Alexander W Pastuszak; Marc Gittelman; James P Tursi; Jonathan S Jaffe; David Schofield; Martin M Miner
Journal:  Andrology       Date:  2021-10-08       Impact factor: 4.456

3.  Testosterone does not affect lower urinary tract symptoms while improving markers of prostatitis in men with benign prostatic hyperplasia: a randomized clinical trial.

Authors:  G Rastrelli; S Cipriani; F Lotti; I Cellai; P Comeglio; S Filippi; V Boddi; P A Della Camera; R Santi; L Boni; G Nesi; S Serni; M Gacci; M Maggi; L Vignozzi
Journal:  J Endocrinol Invest       Date:  2022-03-17       Impact factor: 5.467
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.